GIM
Granahan Investment Management Portfolio holdings
AUM
$2.46B
1-Year Return
66.36%
This Quarter Return
-15.27%
1 Year Return
+66.36%
3 Year Return
+183.04%
5 Year Return
+309.49%
10 Year Return
+1,968.52%
AUM
$1.86B
AUM Growth
-$316M
(-15%)
Cap. Flow
+$95.2M
Cap. Flow
% of AUM
5.12%
Top 10 Holdings %
Top 10 Hldgs %
33.97%
Holding
201
New
20
Increased
89
Reduced
75
Closed
17
Top Buys
| 1 |
Axon Enterprise
AXON
|
$24.5M |
| 2 |
Trade Desk
TTD
|
$21.1M |
| 3 |
LivePerson
LPSN
|
$15.9M |
| 4 |
Bright Horizons
BFAM
|
$15.8M |
| 5 |
EverQuote
EVER
|
$14.2M |
Top Sells
| 1 |
eHealth
EHTH
|
$27.8M |
| 2 |
Teladoc Health
TDOC
|
$25.2M |
| 3 |
MDCO
Medicines Co
MDCO
|
$23.4M |
| 4 |
CoStar Group
CSGP
|
$21.6M |
| 5 |
Enphase Energy
ENPH
|
$20.1M |
Sector Composition
| 1 | Technology | 35.7% |
| 2 | Healthcare | 18.21% |
| 3 | Industrials | 12.95% |
| 4 | Consumer Staples | 7.14% |
| 5 | Consumer Discretionary | 6.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CSPR
126
DELISTED
Casper Sleep Inc.
CSPR
| $2.09M | 0.11% |
+487,009
| New | +$2.09M |
|
127
Monolithic Power Systems
MPWR
$40.6B
| $2.06M | 0.11% |
12,309
+7
| +0.1% | +$1.17K |
|
128
Liquidity Services
LQDT
$841M
| $2.05M | 0.11% |
529,214
+90,442
| +21% | +$351K |
|
|
PFPT
129
DELISTED
Proofpoint, Inc.
PFPT
| $2.05M | 0.11% |
19,983
+2,537
| +15% | +$260K |
|
130
CytomX Therapeutics
CTMX
$346M
| $2.04M | 0.11% |
265,673
+111,855
| +73% | +$858K |
|
131
Sonic Automotive
SAH
$2.79B
| $2.03M | 0.11% |
+153,035
| New | +$2.03M |
|
132
Ring Energy
REI
$205M
| $2.03M | 0.11% |
3,075,245
+1,103,772
| +56% | +$727K |
|
133
Korro Bio
KRRO
$264M
| $1.98M | 0.11% |
2,224
-1,156
| -34% | -$1.03M |
|
134
Protolabs
PRLB
$1.2B
| $1.93M | 0.1% |
25,335
+2,437
| +11% | +$186K |
|
135
Teradyne
TER
$19B
| $1.9M | 0.1% |
35,037
-5,068
| -13% | -$275K |
|
136
Nutanix
NTNX
$18.4B
| $1.89M | 0.1% |
119,470
+2,273
| +2% | +$35.9K |
|
137
Standard BioTools
LAB
$493M
| $1.89M | 0.1% |
742,715
+56,971
| +8% | +$145K |
|
|
NEWR
138
DELISTED
New Relic, Inc.
NEWR
| $1.88M | 0.1% |
40,633
+2,664
| +7% | +$123K |
|
139
Vicor
VICR
$2.33B
| $1.88M | 0.1% |
+42,169
| New | +$1.88M |
|
|
RWT
140
Redwood Trust
RWT
$793M
| $1.83M | 0.1% |
+362,486
| New | +$1.83M |
|
|
AUTL
141
Autolus Therapeutics
AUTL
$386M
| $1.81M | 0.1% |
301,725
-3,433
| -1% | -$20.6K |
|
142
Beam Therapeutics
BEAM
$1.88B
| $1.77M | 0.1% |
+98,276
| New | +$1.77M |
|
143
Silicon Laboratories
SLAB
$4.43B
| $1.73M | 0.09% |
20,194
+822
| +4% | +$70.2K |
|
|
NPTN
144
DELISTED
NEOPHOTONICS CORP
NPTN
| $1.7M | 0.09% |
+233,924
| New | +$1.7M |
|
145
Texas Capital Bancshares
TCBI
$3.99B
| $1.65M | 0.09% |
74,369
+11,070
| +17% | +$245K |
|
|
SIEN
146
DELISTED
Sientra, Inc.
SIEN
| $1.61M | 0.09% |
80,997
+5,024
| +7% | +$100K |
|
147
Fennec Pharmaceuticals
FENC
$255M
| $1.61M | 0.09% |
270,209
-115,671
| -30% | -$687K |
|
|
AERI
148
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $1.6M | 0.09% |
118,278
-128,301
| -52% | -$1.73M |
|
149
DexCom
DXCM
$31.7B
| $1.47M | 0.08% |
21,860
-46,640
| -68% | -$3.14M |
|
150
Encore Capital Group
ECPG
$964M
| $1.47M | 0.08% |
62,643
-21,060
| -25% | -$493K |
|